Physician profile
Carrie E Herthel
NPI 1437519519
$6,621.00
in general payments reported to CMS, 2019-2025
26 companies · $1,301 in 2025
The $1,301 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,205 · 2022: $1,063 · 2023: $1,575 · 2024: $1,478 · 2025: $1,301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,353.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,035.18 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Kyphon Express II Kyphopak Tray |
| Abbott Laboratories | $998.27 | 2022-2024 | Proclaim, Eterna |
| Relievant Medsystems, INC. | $989.76 | 2021-2023 | Intracept |
| Boston Scientific Corporation | $957.34 | 2021-2025 | General - Therapies, Wavewriter Alpha Prime 16, Intracept |
| Abbvie INC. | $933.75 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $216.84 | 2023-2025 | Belbuca, Xtampza |
| Biotronik Nro, INC. | $207.76 | 2025 | Prospera |
| Curonix LLC | $204.45 | 2022-2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertos Medical, INC. | $201.96 | 2021-2023 | Mild Device Kit |
| Nevro Corp. | $177.83 | 2022-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $98.63 | 2022-2025 | Relistor |
| Protega Pharmaceutials INC | $93.97 | 2022 | |
| Pfizer INC. | $84.69 | 2023-2025 | |
| Globus Medical, INC. | $68.17 | 2025 | Senza, Vyrsa V1 |
| Biodelivery Sciences International, INC. | $58.24 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $46.70 | 2021 | |
| Spr Therapeutics, INC | $39.23 | 2024 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $31.10 | 2025 | |
| Saluda Medical Americas, INC. | $29.76 | 2024 | Evoke |
| Amgen INC. | $28.42 | 2021-2024 | Evenity |
| Nalu Medical, INC. | $25.09 | 2024 | Nalu Neurostimulation System |
| Biohaven Pharmaceuticals, INC. | $24.72 | 2021 | |
| Genzyme Corporation | $23.49 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $18.17 | 2023 | Exparel, Zilretta, Iovera |
| Biohaven Pharmaceutical Holding Company Ltd. | $16.35 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $11.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Herthel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.